|
Market Closed -
NYSE
00:00:00 18/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 1.060 USD | -0.93% |
|
-6.19% | -36.53% |
| 08-07 | Lineage Cell Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 | |
| 08-07 | Lineage Cell Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.93% | -6.19% | -8.62% | -15.20% | -36.53% | -11.67% | -23.19% | -56.56% | -66.24% | 268M | |
| +0.68% | -2.28% | -0.25% | +20.66% | +5.32% | +2.16% | +19.70% | -23.29% | +205.17% | 48.84B | |
| +4.07% | +2.43% | +13.88% | +45.54% | +166.16% | +483.70% | +623.80% | +700.60% | - | 45.44B | |
| +4.33% | +0.98% | +16.18% | +23.61% | +19.32% | +12.80% | +88.53% | +28.76% | +1,184.59% | 41.22B | |
| +1.94% | -0.31% | +16.96% | +42.64% | +7.02% | +26.24% | +12.62% | -6.15% | +220.37% | 39.71B | |
| -0.50% | 0.00% | +14.33% | +11.78% | +16.60% | +20.60% | +60.49% | -10.77% | +151.13% | 32.6B | |
| -0.44% | -3.22% | -5.21% | +2.87% | - | - | - | - | - | 16.25B | |
| +3.22% | -0.88% | +11.04% | +43.79% | +6.32% | +30.42% | +135.47% | +232.75% | +2,021.96% | 16.67B | |
| -0.62% | -0.06% | -0.40% | +18.08% | +12.18% | +3.46% | +27.74% | -40.25% | +89.04% | 14.08B | |
| +2.35% | +3.48% | +27.76% | +90.02% | +43.69% | +82.95% | +43.41% | -31.34% | +245.68% | 13.68B | |
| +3.86% | +2.05% | -0.32% | +45.60% | -7.01% | -3.63% | -32.76% | -29.91% | +123.73% | 13.07B | |
| +2.02% | +6.55% | +41.23% | +88.45% | +76.26% | +65.76% | +77.19% | -37.60% | - | 12.37B | |
| -0.01% | +0.37% | +0.37% | +67.18% | +23.09% | +35.06% | -9.78% | -38.91% | +158.19% | 11.28B | |
| +3.12% | -4.68% | -11.16% | +6.92% | -12.04% | +76.50% | +522.94% | +316.93% | +2,362.79% | 10.57B | |
| +2.61% | +2.57% | +19.71% | +9.87% | +27.70% | +699.45% | +1,772.54% | +61.36% | - | 10.51B | |
| +0.03% | -0.04% | +0.44% | +65.87% | +78.31% | +260.93% | +470.30% | - | - | 10.15B | |
| +2.27% | +5.75% | +12.57% | +55.24% | +81.61% | +182.90% | +745.97% | +228.54% | +1,251.11% | 10.26B | |
| +3.42% | +11.82% | +4.87% | +47.68% | +56.03% | +184.80% | +541.70% | +132.81% | - | 10.1B | |
| +2.43% | +2.97% | +7.80% | -21.02% | -25.89% | +33.92% | +49.83% | +51.26% | +70.73% | 9.74B | |
| -0.88% | -6.21% | -1.58% | +17.55% | -12.55% | -30.01% | - | - | - | 9.32B | |
| Average | +1.65% | +1.17% | +7.98% | +33.36% | +27.66% | +113.49% | +284.81% | +86.96% | +616.79% | 18.81B | |
| Weighted average by Cap. | +1.96% | +0.78% | +9.95% | +33.74% | +37.22% | +116.08% | +232.83% | +120.57% | +582.96% |
- Stock Market
- Stocks
- LCTX Stock
- Sector Lineage Cell Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
